| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Jan, 2026 | Jan, 2026 |
| Sales | 2,690 | 2,460 | 2,690 | 0 | 0 |
| Sales Growth | +9.35% | -8.55% | unch | unch | unch |
| Net Income | -8,240 | -14,630 | -4,780 | 0 | 0 |
| Net Income Growth | +43.68% | -206.07% | unch | unch | unch |
Neuraxis Inc (NRXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
NeurAxis, Inc. is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. NeurAxis, Inc. is based in CARMEL, Ind.
Fiscal Year End Date: 12/31